Twice-a-year shot to prevent HIV approved in U.S.
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, its maker Gilead Sciences announced Wednesday.
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, its maker Gilead Sciences announced Wednesday.
It’s the first step in an anticipated global rollout that could protect millions — although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.
While a vaccine to prevent HIV still is needed, some experts say this medication — a drug called lenacapavir — could be the next best thing. It nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.
“This really has the possibility of ending HIV transmission,” said Greg Millett, public policy director at amfAR, the Foundation for AIDS Research.
Read more: https://www.cbc.ca/news/health/lenacapvir-fda-1.7564882
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.